Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex.

Planz O, Pleschka S, Oesterle K, Berberich-Siebelt F, Ehrhardt C, Stitz L, Ludwig S.

J Virol. 2003 Oct;77(20):11186-92.

2.

Borna disease virus nucleoprotein inhibits type I interferon induction through the interferon regulatory factor 7 pathway.

Song W, Kao W, Zhai A, Qian J, Li Y, Zhang Q, Zhao H, Hu Y, Li H, Zhang F.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):619-23. doi: 10.1016/j.bbrc.2013.08.006. Epub 2013 Aug 11.

PMID:
23939047
3.

Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.

Qiao M, Shapiro P, Fosbrink M, Rus H, Kumar R, Passaniti A.

J Biol Chem. 2006 Mar 17;281(11):7118-28. Epub 2006 Jan 9.

4.
5.

Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites.

Yang J, Song H, Walsh S, Bardes ES, Kornbluth S.

J Biol Chem. 2001 Feb 2;276(5):3604-9. Epub 2000 Nov 1.

6.

Borna disease virus phosphoprotein represses p53-mediated transcriptional activity by interference with HMGB1.

Zhang G, Kobayashi T, Kamitani W, Komoto S, Yamashita M, Baba S, Yanai H, Ikuta K, Tomonaga K.

J Virol. 2003 Nov;77(22):12243-51.

7.

Mutation of the protein kinase C site in borna disease virus phosphoprotein abrogates viral interference with neuronal signaling and restores normal synaptic activity.

Prat CM, Schmid S, Farrugia F, Cenac N, Le Masson G, Schwemmle M, Gonzalez-Dunia D.

PLoS Pathog. 2009 May;5(5):e1000425. doi: 10.1371/journal.ppat.1000425. Epub 2009 May 8.

9.

Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.

Nomura N, Nomura M, Newcomb EW, Zagzag D.

Biochem Pharmacol. 2007 May 15;73(10):1528-36. Epub 2007 Jan 21.

PMID:
17324379
10.

Restricted expression of Borna disease virus glycoprotein in brains of experimentally infected Lewis rats.

Werner-Keiss N, Garten W, Richt JA, Porombka D, Algermissen D, Herzog S, Baumgärtner W, Herden C.

Neuropathol Appl Neurobiol. 2008 Dec;34(6):590-602. doi: 10.1111/j.1365-2990.2008.00940.x. Epub 2008 Feb 14.

PMID:
18282160
12.

Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.

Planz O, Stitz L.

J Virol. 1999 Feb;73(2):1715-8. Erratum in: J Virol 1999 May;73(5):4530.

13.

Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components.

Geib T, Sauder C, Venturelli S, Hässler C, Staeheli P, Schwemmle M.

J Virol. 2003 Apr;77(7):4283-90.

14.

Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.

Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace AJ Jr.

Oncogene. 1999 May 6;18(18):2892-900.

15.

Viral interference with neuronal integrity: what can we learn from the Borna disease virus?

Schwemmle M, Heimrich B.

Cell Tissue Res. 2011 Apr;344(1):13-6. doi: 10.1007/s00441-011-1141-6. Epub 2011 Feb 18.

PMID:
21331522
17.

Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.

De Souza CP, Ellem KA, Gabrielli BG.

Exp Cell Res. 2000 May 25;257(1):11-21.

PMID:
10854050
18.

Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.

Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY.

Cancer Res. 2000 Feb 1;60(3):542-5.

20.

Adaptation of Borna disease virus to new host species attributed to altered regulation of viral polymerase activity.

Ackermann A, Staeheli P, Schneider U.

J Virol. 2007 Aug;81(15):7933-40. Epub 2007 May 23.

Supplemental Content

Support Center